"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant B3GNT3

Réf. : BL-RE-054019Réf. fabricant : 18309270 0.1mL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10331
Espèces
Human
Méthode de purification
Chromatography
Pureté
>80%
Concentration
0.5mg/mL
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human B3GNT3. The B3GNT3 Recombinant Protein Antigen is derived from E. coli. The B3GNT3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP1-88953. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-054019
Réf. fabricant18309270
Gene ID (Entrez)10331
EspècesHuman
Méthode de purificationChromatography
Pureté>80%
Concentration0.5mg/mL
Contenu et stockageStore at -20°C. Avoid freeze-thaw cycles.
FormulePBS and 1M Urea, pH 7.4.
À utiliser avec (application)Blocking/Neutralizing, Control
Alias de gèneb3Gal-T8, B3GALT8, B3GN-T3, B3GNT-3, Beta-1,3-galactosyltransferase 8, Beta-1,3-GalTase 8, beta-1,3-Gn-T3, Beta-1,3-N-acetylglucosaminyltransferase 3, beta-1,3-N-acetylglucosaminyltransferase bGnT-3, beta3GalT8, Beta3Gal-T8, beta3Gn-T3, beta-3-Gx-T8, BGnT-3, Core 1 extending beta-1,3-N-acetylglucosaminyltransferase, Core1-beta3GlcNAcT, EC 2.4.1, EC 2.4.1.-, HP10328, putative type II membrane protein, TMEM3beta3Gal-T8, transmembrane protein 3, UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8, UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
Symbole de gène(s)B3GNT3
Type d’étiquetteUnlabeled
Poids moléculaire34kDa
Type de produitB3GNT3
Quantité0.1mL
État réglementaireRUO
SourceE.Coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP1-88953. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
ImmunogèneLLQDVPPSKCAQPVFLLLVIKSSPSNYVRRELLRRTWGRERKVRGLQLRLLFLVGTASNPHEARKVNRLLELEAQTHGDILQWDFHDSFFNLTLKQVLFLQWQETRCANASFVLNGDDDVFAHTDNMVFYLQDHDPGRHLFV
Une question, une configuration particulière ?
Contactez-nous pour un devis.